Ghouse J, Ahlberg G, Rand SA, et al. Potential Influence of Risk Factor Control on the Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease. Arteriosclerosis, thrombosis, and vascular biology. 2024. doi:10.1161/ATVBAHA.124.320990.

Nagiec MM, Skepner AP, Negri J, et al. Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression. PLoS One. 2015;10(3):e0120295. doi:10.1371/journal.pone.0120295.

Khera AV, Won H-H, Peloso GM, et al. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease. JAMA. 2017;317(9):937-946. doi:10.1001/jama.2017.0972.

Nath AP, Ritchie SC, Byars SG, et al. An interaction map of circulating metabolites, immune gene networks, and their genetic regulation. Genome Biol. 2017;18(1):146. doi:10.1186/s13059-017-1279-y.

Khetarpal SA, Zeng X, Millar JS, et al. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. Nat Med. 2017;23(9):1086-1094. doi:10.1038/nm.4390.

Tynkkynen J, Chouraki V, Van der Lee SJ, et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer’s disease: A prospective study in eight cohorts. Alzheimers Dement. 2018;14(6):723-733. doi:10.1016/j.jalz.2018.01.003.

Wagschal A, Najafi-Shoushtari H, Wang L, et al. Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Nat Med. 2015;21(11):1290-7. doi:10.1038/nm.3980.